The personalized nutrition and lifestyle startup sells subscription-based at-home urine test kits that work in conjunction with an app. She adds that the startup sees CGM as a “complementary technology” — envisaging a partnership with a device maker down the line (“since the data is complementary to Vivoo data sets, and our users are always seeking more information”). We’re excited to work with Vivoo as the company expands its footprint globally.”Eat this, exercise now; new personalized software predicts and helps prevent blood sugar spikes “Our biggest audience is 25-45 year old women users followed by the same age group male users. “Around 80% of our users also use other trackers such as wearable devices and who did or would like to do tests like genetic and microbiome at-home tests.”Vivoo says the Series A funding will mostly go on expanding its team to further scale the business — with a focus on the US, where it has already inked partnerships with retail outlets including Amazon and Walmart to distribute the product. Vivoo — by contrast — is using a fairly simple, low mess, non-invasive avenue to get snapshots of biological data: Pee sticks. Vivoo says it’s using machine learning technology to perform this remote urine analysis — including what it bills as “advanced image and color processes for calibration, validation, and verification” (i.e. given how much variation there is across smartphone camera hardware). Vivoo says its product offers a range of wellness “parameters” that health-conscious users can track — including overall hydration; menstruation; whether they have an infection (e.g. UTI) or bodily inflammation (tracked by analysis of white blood cells); their urine’s acidity and alkalinity level (used as a dietary indicator); ketones (mainly for those on a ‌‌ketogenic‌ ‌diet); and the function of their liver and kidney.“Users can access data on 15 health factors, including hydration, pH balance, ketones, calcium, magnesium, Vitamin C, free radicals, kidney function, liver function, UTI risk, activity levels, stress levels, menstruation, and overall wellness,” it writes in a press release.There’s a lot of tracking going on here so it’s clearly not the simplest personalized health message. “Our urine tests are registered with the FDA but the app is not as it’s not a diagnostic device but a data tracking tool,” she adds when asked whether Vivoo has plans to apply for the app to be regulated as a medical device in the future.“We have plans to extend the capabilities of the application in the future, and we may consider adding metrics that can help chronic disease sufferers to track and share their data with their healthcare professionals.